Urmil Shukla, MD
General Surgery · Huntsville, TXNPI 1144207317
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,779 of the $3,621 with a category attached, or 76.8%. TELA Bio, Inc. accounts for 66.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $2,329 and has fallen 89.5% since, to $245 in 2025.
Across 30 payments — averaging $120.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$2K
- Medical Device Business Services, Inc.$588
- Stryker$552
- Intuitive Surgical$45
- Johnson & Johnson$24
- Wound Management Technologies, Inc$7
What the payments were for
- Travel & lodging$2,77977%
- Food & beverage$84123%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 15 | $2,406 |
| Medical Device Business Services, Inc. | 11 | $588 |
| Stryker | 1 | $552 |
| Intuitive Surgical | 1 | $45 |
| Johnson & Johnson | 1 | $24 |
| Wound Management Technologies, Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OviTex 2S$2,062
- 1588 HD 3 CHIP CAMERA$552
- STRATAFIX$297
- HARMONIC Product Family$297
- ECHELON FLEX Stapler$297
How this compares
$3,621 in reported general payments places this provider in the 75th percentile of 61 general surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 154 | $2,140 |
| Sucralfate | 88 | $1,041 |
| Omeprazole | 58 | $799 |
| Megestrol Acetate | 11 | $457 |
| Famotidine | 27 | $313 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $283 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 56 | $276 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 15 | $153 |
| Nystatin | 16 | $145 |
| Metronidazole | 27 | $137 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Huntsville
- Omar BarakatHouston$145K
- Adam SmithFort Worth$62K
- Aaron BranskyPlano$32K
- Michael DarnellFt Worth$18K
- Jay StaufferFredericksburg$17K
- Younan NowzaradanHouston$13K
- Dean KocayAustin$10K
- Rusty MilhoanArlington$9K
- Frank DuperierSan Antonio$8K
- David SynLubbock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.